Harshad Lalwani, Founder, Hummsa Biotech, explains, GLP-1based therapies have moved from diabetes into broad metabolic care and obesity, with rapid adoption
I can really say this is a very good product
A popular diabetes medication has been found to prevent kidney failure and reduce deaths in people with type 2 diabetes and chronic kidney disease
Contact your GP or prescribing clinician if you experience: Persistent or severe nausea and vomiting that prevents adequate food or fluid intake, particularly if lasting more than 24-48 hours, as this raises concerns about dehydration and nutritional deficiency Severe abdominal pain , especially if sharp, persistent, or located in the upper abdomen radiating to the back, which could indicate pancreatitisa rare but serious adverse effect of GLP-1 receptor agonists mentioned in the Wegovy SmPC [8] [4] Signs of dehydration including dark urine, dizziness, reduced urination, or extreme thirst Rapid or unintended weight loss that exceeds your expected rate Blood in vomit or stools , which requires urgent assessment (call NHS 111 or 999, or attend A&E) Symptoms of gallbladder disease such as severe right upper abdominal pain, particularly after fatty meals, as rapid weight loss can increase gallstone risk (noted in the Wegovy SmPC) [4] [9] Severe constipation with abdominal distension , which could indicate bowel obstruction Dietary intolerances that significantly impact quality of life or nutritional adequacy should also be discussed with your healthcare team
Diabetes & Endocrinology, 10 (6), 418429
Inject Semaglutide immediately in the event of missing a dose, with the next scheduled dose having a gap of more than 48 hours
:max_bytes(150000):strip_icc():focal(745x164:747x166)/Ozempic-costco-040324-tout-9c37daf8c3eb4ae5936e85c87b840495.jpg)
